Latest News and Press Releases
Want to stay updated on the latest news?
-
New class action filing lets Wildermuth Fund investors seek recovery for alleged securities fraud violations. Lead plaintiff deadline: December 29, 2025.
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fiserv (FISV) To Contact Him Directly To Discuss Their Options If you purchased or...
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Target (TGT) To Contact Him Directly To Discuss Their Options If you are a long-term...
-
New class action filing lets Wildermuth Fund investors seek recovery for alleged securities fraud violations. Lead plaintiff deadline: December 29, 2025.
-
The complaint alleges Fiserv misled investors about initiative delays and guidance, relying on unrealistic assumptions that inflated the stock price.
-
New class action filing lets Wildermuth Fund investors seek recovery for alleged securities fraud violations. Lead plaintiff deadline: December 29, 2025.
-
Grindr Inc. shareholders are encouraged to contact BFA Law about its investigation into the take-private transaction.
-
On May 27, 2025, Savara revealed the FDA refused to file its MOLBREEVI BLA due to insufficient CMC data, causing shares to fall $0.90, or 31.69%, to $1.94.
-
Allegedly, defendants hid unauthorized FDA design changes to DexCom’s G6 and G7, making them less reliable and exposing users to health risks.
-
The complaint alleges Fiserv misled investors about its 2025 initiatives, later admitting its guidance was based on assumptions that were unrealistic.